These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10906759)

  • 1. Leukemia-associated AML1/ETO (8;21) chromosomal translocation protein increases the cellular representation of PML bodies.
    McNeil S; Javed A; Harrington KS; Lian JB; Stein JL; van Wijnen AJ; Stein GS
    J Cell Biochem; 2000 Jul; 79(1):103-12. PubMed ID: 10906759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
    Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW
    Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins.
    Barseguian K; Lutterbach B; Hiebert SW; Nickerson J; Lian JB; Stein JL; van Wijnen AJ; Stein GS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15434-9. PubMed ID: 12427969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 8;21 translocation in leukemogenesis.
    Peterson LF; Zhang DE
    Oncogene; 2004 May; 23(24):4255-62. PubMed ID: 15156181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant translocation t(2;21;8)(q36;q22;q22) with RUNX1/CBFA2T1 (AML1/ETO) transcript in a case of acute myelogenous leukemia.
    Hsiao HH; Sashida G; Kodama A; Fukutake K; Ohyashiki K
    Cancer Genet Cytogenet; 2005 May; 159(1):96-7. PubMed ID: 15860366
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of the nuclear distribution of the translocation t(8;21)-derived fusion protein AML1/ETO by confocal laser scanning microscopy.
    Nagel S; Hambach L; Krauter J; Venturini L; Heidenreich O; Ganser A; Heil G
    J Hematother Stem Cell Res; 2002 Apr; 11(2):401-8. PubMed ID: 11983111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
    Licht JD
    Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells.
    Li X; Xu YB; Wang Q; Lu Y; Zheng Y; Wang YC; Lübbert M; Zhao KW; Chen GQ
    J Cell Physiol; 2006 Sep; 208(3):594-601. PubMed ID: 16741927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.
    Fliegauf M; Stock M; Berg T; Lübbert M
    Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the AML1-ETO fusion transcript expression in children and young adults with t(8;21) acute myeloid leukemia.
    Fleischman EW; Baturina JA; Sokova OI; Popa AV; Kosorukova IS; Rowley JD
    Haematologica; 2003 Sep; 88(9):1078-9. PubMed ID: 12969821
    [No Abstract]   [Full Text] [Related]  

  • 13. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
    Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission.
    Buonamici S; Ottaviani E; Visani G; Bonifazi F; Fiacchini M; Baccarani M; Martinelli G
    Haematologica; 2004 Jan; 89(1):103-5. PubMed ID: 14754613
    [No Abstract]   [Full Text] [Related]  

  • 15. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
    Kasashima K; Sakota E; Kozu T
    Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells.
    Nimer SD; Moore MA
    Oncogene; 2004 May; 23(24):4249-54. PubMed ID: 15156180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
    Mikhail FM; Coignet L; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Farahat N; Nucifora G
    Genes Chromosomes Cancer; 2004 Feb; 39(2):110-8. PubMed ID: 14695990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous PML/RARalpha and AML1/ETO expression with t(15;17) at onset and relapse with only t(8;21) in an acute promyelocytic leukemia patient.
    Bonomi R; Giordano H; del Pilar Moreno M; Bodega E; Landoni AI; Gallagher R; del Rosario Uriarte M
    Cancer Genet Cytogenet; 2000 Nov; 123(1):41-3. PubMed ID: 11120332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8).
    Odaka Y; Mally A; Elliott LT; Meyers S
    Oncogene; 2000 Jul; 19(32):3584-97. PubMed ID: 10951564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
    Zhang Y; Emmanuel N; Kamboj G; Chen J; Shurafa M; Van Dyke DL; Wiktor A; Rowley JD
    Genes Chromosomes Cancer; 2004 Aug; 40(4):365-70. PubMed ID: 15188461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.